Literature DB >> 16126843

Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.

Yasunari Morimoto1, Yang Bian, Ping Gao, Yumi Yashiro-Ohtani, Xu-Yu Zhou, Shiro Ono, Hirokazu Nakahara, Mikihiko Kogo, Toshiyuki Hamaoka, Hiromi Fujiwara.   

Abstract

T helper cell type 1 (Th1) and Th2 cells express distinct sets of chemokine receptors. In contrast to Th1 chemokine receptors, it is largely unknown how Th2 chemokine receptors such as CC chemokine receptor 4 (CCR4) are induced during Th2 differentiation. Here, we investigated the induction of CCR4 surface expression and ligand responsiveness evaluated by functional assays such as chemokine binding and chemotaxis. This was done in comparison with those of a Th1 chemokine receptor, CXC chemokine receptor 3 (CXCR3). Resting T cells expressed neither CXCR3 nor CCR4. CXCR3 expression and ligand responsiveness were observed when resting T cells were stimulated with anti-CD3 plus anti-CD28 in the presence of [interleukin (IL)-12+anti-IL-4] and then recultured without T cell receptor (TCR) stimulation. Unlike CXCR3, CCR4 was induced immediately after anti-CD3/anti-CD28 stimulation in the presence of (IL-4+anti-interferon-gamma+anti-IL-12). However, these CCR4-positive cells failed to exhibit chemokine binding and chemotaxis. Although the levels of surface CCR4 expression were not increased after the subsequent reculture in the absence of TCR stimulation, CCR4 responsiveness was induced in this stage of Th2 cells. The induction of CCR4 expression and the acquisition of CCR4 responsiveness did not occur in IL-4-deficient (IL-4(-/-)) and signal transducer and activator of transcription (STAT)6(-/-) T cells. CCR4 expression and functionality were regained in IL-4(-/-) but not in STAT6(-/-) T cells by the addition of recombinant IL-4. Although surface expression and functionality of CCR4 are induced depending on the IL-4/STAT6 signaling pathway, the present results indicate that the functionality of CCR4 does not correlate with CCR4 expression but emerges at later stages of Th2 differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126843     DOI: 10.1189/jlb.0305139

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.

Authors:  Matthew R Farren; Rebecca C Hennessey; Reena Shakya; Omar Elnaggar; Gregory Young; Kari Kendra; Yosef Landesman; Sivan Elloul; Marsha Crochiere; Boris Klebanov; Trinayan Kashyap; Christin E Burd; Gregory B Lesinski
Journal:  Mol Cancer Ther       Date:  2017-02-01       Impact factor: 6.261

2.  Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Authors:  Yu Yu; Dapeng Wang; Chen Liu; Kane Kaosaard; Kenrick Semple; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

3.  Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.

Authors:  Nadine M Lerret; Ting Li; Jiao-Jing Wang; Hee-Kap Kang; Sheng Wang; Xueqiong Wang; Chunfa Jie; Yashpal S Kanwar; Michael M Abecassis; Xunrong Luo; Zheng Zhang
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Cutting edge: STAT6 signaling in eosinophils is necessary for development of allergic airway inflammation.

Authors:  Kindra Stokes; Nelson M LaMarche; Nasif Islam; Amie Wood; Weishan Huang; Avery August
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

5.  Lung transplantation affects expression of the chemokine receptor type 4 on specific T cell subsets.

Authors:  A W M Paantjens; E A van de Graaf; J M Kwakkel-van Erp; T Hoefnagel; D A van Kessel; J M M van den Bosch; H G Otten
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

6.  c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice.

Authors:  Yu Yu; Dapeng Wang; Kane Kaosaard; Chen Liu; Jianing Fu; Kelley Haarberg; Claudio Anasetti; Amer A Beg; Xue-Zhong Yu
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

7.  Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages.

Authors:  Ying Liu; Keqiang Chen; Chunyan Wang; Wanghua Gong; Teizo Yoshimura; Mingyong Liu; Ji Ming Wang
Journal:  Cancer Res       Date:  2012-11-08       Impact factor: 12.701

Review 8.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

9.  Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.

Authors:  Urs B Hagemann; Lavinia Gunnarsson; Solène Géraudie; Ulrike Scheffler; Remko A Griep; Herald Reiersen; Alexander R Duncan; Sergej M Kiprijanov
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

Review 10.  Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.

Authors:  Alyssa Mitson-Salazar; Calman Prussin
Journal:  Front Med (Lausanne)       Date:  2017-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.